We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$11.9B
AUM Growth
+$1.4B
Cap. Flow
+$748M
Cap. Flow %
6.3%
Top 10 Hldgs %
12.11%
Holding
747
New
202
Increased
220
Reduced
153
Closed
161

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$134M
2
STM icon
STMicroelectronics
STM
+$103M
3
META icon
Meta Platforms (Facebook)
META
+$89.9M
4
MET icon
MetLife
MET
+$71.9M
5
GILD icon
Gilead Sciences
GILD
+$70.3M

Top Sells

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$161M
2
LLY icon
Eli Lilly
LLY
+$153M
3
MRSH
Marsh
MRSH
+$123M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$91.8M
5
EA icon
Electronic Arts
EA
+$79.5M

Sector Composition

Rank Sector Weight
1 Healthcare 43.43%
2 Technology 17.4%
3 Industrials 8.07%
4 Energy 6.4%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AR icon
601
Antero Resources
AR
$10.6B
-823,719
Closed -$26.9M
ASAN icon
602
Asana
ASAN
$1.98B
-28,830
Closed -$403K
ATRA icon
603
Atara Biotherapeutics
ATRA
$75.5M
-70,889
Closed -$603K
AVT icon
604
Avnet
AVT
$8.03B
-134,423
Closed -$6.92M
AXON
605
Axon Enterprise
AXON
$45.2B
-1,807
Closed -$532K
BCYC
606
Bicycle Therapeutics
BCYC
$278M
-586,622
Closed -$11.9M
BHF icon
607
Brighthouse Financial
BHF
$3.54B
-44,737
Closed -$1.94M
BLUE
608
DELISTED
bluebird bio
BLUE
-48,467
Closed -$954K
BR icon
609
Broadridge
BR
$18.5B
-1,068
Closed -$210K
BRBR icon
610
BellRing Brands
BRBR
$1.41B
-99,574
Closed -$5.69M
BRO icon
611
Brown & Brown
BRO
$23.8B
-259,029
Closed -$23.2M
CABA icon
612
Cabaletta Bio
CABA
$455M
-242,981
Closed -$1.82M
CARR icon
613
Carrier Global
CARR
$54B
-216,779
Closed -$13.7M
CCK icon
614
Crown Holdings
CCK
$13.2B
-123,350
Closed -$9.18M
CHKP icon
615
Check Point Software Technologies
CHKP
$12.6B
-153,230
Closed -$25.3M
CHRS icon
616
Coherus Oncology
CHRS
$213M
-322,680
Closed -$558K
CIEN icon
617
Ciena
CIEN
$59.1B
-316,190
Closed -$15.2M
COHU icon
618
Cohu
COHU
$2.49B
-8,454
Closed -$280K
COR icon
619
Cencora
COR
$61.3B
-35,836
Closed -$8.07M
COTY icon
620
Coty
COTY
$2.47B
-403,904
Closed -$4.05M
CRBG icon
621
Corebridge Financial
CRBG
$15.1B
-1,416,160
Closed -$41.2M
CRBP icon
622
Corbus Pharmaceuticals
CRBP
$179M
-249,259
Closed -$11.3M
DDOG icon
623
Datadog
DDOG
$86B
-15,179
Closed -$1.97M
DHI icon
624
D.R. Horton
DHI
$41.1B
-61,468
Closed -$8.66M
DNLI icon
625
Denali Therapeutics
DNLI
$3.91B
-56,554
Closed -$1.31M

Similar funds

Woodline Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Woodline Partners held 747 positions worth $11.9B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Woodline Partners deployed $748M of net new capital in Q3 2024, opening 202 new positions and adding to 220 existing holdings. Its largest new stake was ASML: 149,876 shares worth $125M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $153M trimmed.

  • Woodline Partners's largest Q3 2024 buy was ASML: 149,876 shares worth $125M.
  • Woodline Partners added most to STMicroelectronics in Q3 2024, an estimated $103M increase.
  • Woodline Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $153M.
  • Woodline Partners fully exited TE Connectivity in Q3 2024, selling an estimated $161M.
  • Woodline Partners's ten largest holdings make up 12% of its $11.9B portfolio in Q3 2024.
  • Woodline Partners opened 202 new positions and closed 161 in Q3 2024.
  • Woodline Partners's portfolio value rose 13% quarter-over-quarter to $11.9B.

Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.